Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Clinical characteristics of acute zonal occult outer retinopathy complicated by chorodal neovascularization (CNV) in our series and in the Levison et al.a report

From: Clinical course of acute zonal occult outer retinopathy complicated by choroidal neovascularization

Patient Presentation Eye with CNV CNV treatment N tretments FU (years) Final BCVA
1 Unilateral LE Beva 3 4 RE 20/20 LE 20/60
2 Bilateral LE Beva 3 2 RE 20/25 LE 20/50
3 Bilateral RE Rani + Afli 12 + 5 3 RE 20/40 LE 20/20
4 Unilateral LE PDT 1 11 RE 20/40b LE 20/20
Levison et al.a Bilateral RE Beva 3 0.4 RE 20/20 LE HM
  1. RE right eye, LE left eye, Beva bevacizumab, Rani Ranibizumab, Afli aflibercept, PDT photodynamic therapy, FU follow-up, BCVA best-corrected visual acuity
  2. aSee Ref. [6]
  3. bWith eccentric vision